United Kingdom · Question · Written question
HL HL16619
Donanemab and Lecanemab
Introduced
21 April 2026
Last action
—
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
29 April 2026
Summary
To ask His Majesty's Government what assessment they have made of clinical trials of donanemab and lecanemab for treating Alzheimer's conditions; and whether they plan to provide those drugs through the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.